Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
438
天
MARCHF6 orchestrates hepatic lipid homeostasis by targeting SREBP1 for ER-associated degradation
作者
Yanan Xu; Tongpeng Yue; Uyanga Batbold; Assa Magassa; Kun Liu; Liping Jiang; Dechen Liu; Long Nguyen Hoang Do; Xiaolei Liu; Ling Yang; Jun Yu; Sheng Wu; Deyu Fang; Xiaofeng Yang; Hong Wang; Xiaoyu Zhang; Ling Leng; Juncheng Wei展开收起
作者单位
Center for Metabolic Disease Research, Department of Cardiovascular Sciences, Temple University Lewis Katz School of Medicine, Philadelphia, PA, 19140, USA; Stem Cell and Regenerative Medicine Lab, National infrastructures for Translational Medicine and State Key Laboratory for Complex, Severe, and Rare Diseases, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China; Department of Chemistry, Northwestern University, Evanston, Illinois, 60208, USA; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA; Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL, 60607, USA; Department of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, China; Lemole Center for Integrated Lymphatics and Vascular Research, Department of Cardiovascular Sciences, Temple University Lewis Katz School of Medicine, Philadelphia, PA 19140, USA; Medical Genetics & Molecular Biochemistry, Lewis Kats School of Medicine, Temple University, Philadelphia, PA, USA展开收起
179
天
siRNA JNJ-73763989 decreases HBsAg and HDV RNA in NA-treated hepatitis D patients but may cause ALT flares
作者
Heiner Wedemeyer; Ed Gane; Kosh Agarwal; Ömer Fehmi Tabak; Xavier Forns; Ulus Salih Akarca; Viacheslav Morozov; Soo Aleman; Maria Buti; Gurdal Yilmaz; Pietro Lampertico; John Jezorwski; Thomas N. Kakuda; Adam Bakala; Nonko Pehlivanov; Thierry Verbinnen; Oliver Lenz; Michael Biermer展开收起
作者单位
Department of Gastroenterology, Hepatology, Infectious Diseases, and Endocrinology, Hannover Medical School, Hanover, Germany, Excellence Cluster RESIST, D-SOLVE Consortium, Hannover, German Center for Infection Research (DZIF) Partner Site Hannover-Braunschweig, Braunschweig, Germany; New Zealand Liver Transplant Unit, University of Auckland, Auckland, New Zealand; Institute of Liver Studies, King’s College Hospital, London, England; Istanbul University-Cerrahpasa, Department of Infectious Diseases, Istanbul, Turkey; Liver Unit, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, CIBEREHD, Spain; Division of Gastroenterology, Department of Internal Medicine, Ege University Medical Faculty, Izmir, Turkey; Medical Company Hepatolog Ltd, Samara, Russia; Department of Infectious Diseases, Karolinska University Hospital/Karolinska Institutet, Stockholm, Sweden; Hospital General Universitari Valle Hebron and CIBER-EHD del Instituto Carlos III, Barcelona, Spain; Trabzon Karadeniz Technical University Farabi Hospital, Trabzon, Turkey; Division of Gastroenterology and Hepatology, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy; CRC “A. M. and A. Migliavacca” Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Johnson & Johnson, Titusville, NJ, USA; Johnson & Johnson Research & Development, LLC, Brisbane, CA, USA; Johnson & Johnson, Beerse, Belgium展开收起
279
天
Rifaximin ameliorates cirrhotic portal hypertension through suppression of microbiome-derived deoxycholic acid
作者
Hai-Lin Xiong; Qi Zhao; Shu-Qing Liu; Li-Lin Chen; Mei-Tong Nie; Xia-Lu Hong; Chen-Hong Ding; Ru Huang; Nan Jiang; Fei Chen; Yu-Hao Song; Xin Zhang; Ke-Qi Wang; Chang-Peng Zhu; Wei-Fen Xie展开收起
作者单位
Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China; Department of Gastroenterology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China; Department of Gastroenterology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China展开收起
259
天
Arachidonoyl-taurine is elevated in human MASLD and protects against hepatic steatosis and inflammation in preclinical models
作者
Katharina B. Kuentzel; Samuel A.J. Trammell; Anna S. Hassing; Ivan Bradić; Michelle Damgaard; Emma B. Fals; Katja T. Michler; Matthew Dooley; Jens C.B. Jacobsen; Malte P. Suppli; Mikkel P. Werge; Cameron J. Mitchell; Nicolai J. Wewer Albrechtsen; Lise L. Glud; Filip K. Knop; James F. Markworth; Martin R. Larsen; Matthew P. Gillum; Jonas T. Treebak; Jesmund Dalli; Steen Larsen; Trisha J. Grevengoed展开收起
作者单位
Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Department of Clinical Biochemistry, Copenhagen University Hospital—Bispebjerg, Copenhagen, Denmark; Gastro Unit, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark; School of Kinesiology, The University of British Columbia, Canada; Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Present address: Novo Nordisk, Bagsværd, Denmark; Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; Department of Clinical Medicine, University of Copenhagen Faculty of Health and Medical Sciences, Copenhagen, Denmark; Department of Animal Sciences, Purdue University, West Lafayette, IN, USA; Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, London, UK; Institute of Sports Medicine Copenhagen, Department of Orthopedic Surgery M, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Denmark; Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland展开收起
180
天
A multi-analyte cfDNA-based blood test for early detection of hepatocellular carcinoma
作者
David J. Taggart; Shivani Mahajan; Maxime A. Gallant; Itai Pinkoviezky; Jianfeng Xu; Allison J. Sorg; Curt C. Roberts; Dmitri Slinkov; Emmanuel C. Gorospe; Abdullah Mubarak; Bal Raj Bhandari; Bradley Freilich; Nadege Gunn; Ju Dong Yang; John H. Smith; Ziad H. Younes; Roniel Cabrera; Humberto Aguilar; Hrishikesh Samant; Wei Li; Richard A. Van Etten; Mindie H. Nguyen展开收起
作者单位
Helio Genomics, Inc., Irvine, California, USA; Laboratory for Advanced Medicine & Health Ltd. (LAMH), Beijing, China; Texas Gastro Research, El Paso, Texas, USA; Liver Center of Texas, Dallas, Texas, USA; Delta Research Partners, LLC, Bastrop, Louisiana, USA; Kansas City Research Institute, Kansas City, Missouri, USA; Velocity Clinical Research, Waco, Texas, USA; Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, California, USA; Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA; Digestive and Liver Disease Specialists, Norfolk, VA, USA; Gastro One, Germantown, Tennessee, USA; Division of Gastroenterology, Hepatology, and Nutrition, College of Medicine, University of Florida, Gainesville, Florida, USA; Louisiana Research Center, Shreveport, Louisiana, USA; Department of Gastroenterology and Hepatology, Ochsner Health System, New Orleans, Louisiana, USA; Division of Computational Biomedicine, Department of Biological Chemistry, School of Medicine, University of California, Irvine, California, USA; Chao Family Comprehensive Cancer Center and Department of Medicine, School of Medicine, University of California, Irvine, California, USA; Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University Medical Center, California, USA; Department of Epidemiology and Population Health, Stanford University Medical Center, California, USA; Stanford Cancer Institute, Stanford University Medical Center, California, USA展开收起
274
天
CD34+ cell-derived endothelial cells orchestrate vascular and immune remodeling in the transplanted liver
作者
Ruihan Chen; Xinqiang Li; Pengwei Zhu; Xuewen Yi; Ting Wang; Hui Chen; Xueyin Huang; Guoguo Ye; Jingyu Jiang; Meiching Ong; Liujun Jiang; Yali Li; Siyi Zhong; Yangyan He; Rong Fan; Bohuan Zhang; Hongjun Li; Jinzhen Cai; Shusen Zheng; Qingbo Xu; Qi Ling; Hongkun Zhang展开收起
作者单位
Department of Vascular Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Organ Transplantation Center, Affiliated Hospital of Qingdao University, Qingdao, China; Department of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, China; Department of Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital, Hangzhou, China; National Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China; Liangzhu Laboratory, Zhejiang University, Hangzhou, China; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天